# Filing Detail

Form DEFR14A - Revised definitive proxy soliciting materials:
SEC Accession No. 0001104659-22-071482
Filing Date
2022-06-15
Accepted
2022-06-15 16:39:42
Documents
6

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEFR14A | tm223528-3_defr14a.htm | DEFR14A | 868349
2 | GRAPHIC | lg_avadel-4clr.jpg | GRAPHIC | 23951
3 | GRAPHIC | tm223528d3-px_avadelbw.jpg | GRAPHIC | 1408066
4 | GRAPHIC | tm223528d3-px_page01bw.jpg | GRAPHIC | 2020079
5 | GRAPHIC | tm223528d3-px_page02bw.jpg | GRAPHIC | 1868870
6 | GRAPHIC | tm223528d3-px_votebw.jpg | GRAPHIC | 676506
| Complete submission text file | 0001104659-22-071482.txt |  | 9129440

Mailing Address 16640 CHESTERFIELD GROVE ROAD SUITE 200 CHESTERFIELD MO 63005
Business Address BLOCK 10-1 BLANCHARDSTOWN CORPORATE PARK BALLYCOOLIN DUBLIN L2 15 636-449-1830
AVADEL PHARMACEUTICALS PLC (Filer) CIK: 0001012477 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: DEFR14A | Act: 34 | File No.: 001-37977 | Film No.: 221018243
SIC: 2834 Pharmaceutical Preparations